NCT00971802 - A Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Healthy Volunteers

Interventions

DRUG

PF-03882845 or Placebo

PF-03882845 20 mg or Placebo, daily for 10 days.

DRUG

PF-03882845 or Placebo

PF-03882845 60 mg or Placebo, daily for 10 days.

DRUG

PF-03882845 or Placebo

PF-03882845 120 mg or Placebo, daily for 10 days.

DRUG

PF-03882845 or Placebo

PF-03882845 185 mg or Placebo, daily for 10 days.

Trial Locations (1)

Pfizer Investigational Site, South Miami